Detalhe da pesquisa
1.
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
J Transl Med
; 16(1): 287, 2018 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30342534
2.
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases.
Case Rep Oncol
; 14(1): 62-66, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33776683
3.
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.
Med Oncol
; 36(10): 89, 2019 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31520329
4.
Full-dose capecitabine with local radiotherapy: one of the treatment options for inoperable T4 breast cancer.
Jpn J Radiol
; 29(3): 222-5, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21519998